|
CUL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03689999983747E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65710000002528E-07 |
| Normal-vs-Stage2 |
5.739100E-03 |
| Normal-vs-Stage3 |
6.457500E-03 |
| Normal-vs-Stage4 |
8.031100E-04 |
| Stage1-vs-Stage2 |
9.005200E-01 |
| Stage1-vs-Stage3 |
8.544400E-02 |
| Stage1-vs-Stage4 |
7.283200E-01 |
| Stage2-vs-Stage3 |
3.621400E-01 |
| Stage2-vs-Stage4 |
7.316800E-01 |
| Stage3-vs-Stage4 |
1.798960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.08020000014697E-07 |
| Normal-vs-AfricanAmerican |
1.253680E-02 |
| Normal-vs-Asian |
3.337600E-02 |
| Caucasian-vs-AfricanAmerican |
2.468400E-01 |
| Caucasian-vs-Asian |
3.839800E-02 |
| AfricanAmerican-vs-Asian |
9.866300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01990000000995E-06 |
| Normal-vs-Female |
1.93305999999227E-05 |
| Male-vs-Female |
6.378800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.199500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.27250000003798E-06 |
| Normal-vs-Age(61-80Yrs) |
1.59398999999283E-05 |
| Normal-vs-Age(81-100Yrs) |
3.498000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.681200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.656400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.406400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.098600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.956600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.677200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.661240E-03 |
| Normal-vs-Grade 2 |
2.77030000050971E-07 |
| Normal-vs-Grade 3 |
4.351400E-04 |
| Normal-vs-Grade 4 |
1.721730E-03 |
| Grade 1-vs-Grade 2 |
6.439600E-01 |
| Grade 1-vs-Grade 3 |
2.926800E-01 |
| Grade 1-vs-Grade 4 |
6.790400E-01 |
| Grade 2-vs-Grade 3 |
9.191500E-02 |
| Grade 2-vs-Grade 4 |
9.266800E-01 |
| Grade 3-vs-Grade 4 |
2.989200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24849999999055E-05 |
| Normal-vs-ccB subtype |
2.15179999996096E-06 |
| ccA subtype-vs-ccB subtype |
4.087200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46609999995828E-06 |
| Normal-vs-N1 |
8.122400E-02 |
| N0-vs-N1 |
4.429800E-01 |
|
|
